• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy
ConclusionsIt was determined that Ankaferd hemostat is effective in preventing oral mucositis due to chemotherapy in adult patients diagnosed with colorectal cancer. In addition, it has been suggested to conduct new studies on the effectiveness of Ankaferd hemostat in the prevention of mucositis in different groups.Trial registrationThe study was registered at ClinicalTrials.gov (ID: NCT05438771, Date: 25.06.2022).
Source: Supportive Care in Cancer - June 8, 2023 Category: Cancer & Oncology Source Type: research

Severe radiation esophagitis successfully treated with Ankaferd hemostat
Radiation esophagitis is an early and common adverse effect of radiation treatment. Its incidence is greater with higher radiation dose and concurrent chemotherapy. Strictures are the imminent adverse event. Currently, there is no ideal therapy to prevent stricture formation resulting from chemoradiotherapy. We have previously demonstrated the beneficial effect of Ankaferd blood stopper (ABS; Ankaferd Ilaç Kozmetik AS, Istanbul, Turkey), a recently developed hemostatic agent, in the treatment of caustic esophagitis in an experimental model.
Source: Gastrointestinal Endoscopy - March 24, 2015 Category: Gastroenterology Authors: Omer Ozturk, Seyfettin Koklu, Omer Basar, Ibrahim C. Haznedaroglu Tags: Letter to the Editor Source Type: research